Tandem Diabetes Taps Jeannette Bankes as New President and CEO
TNDM sits 71% above its 52-week low of $12.26.
Summary
Tandem Diabetes Care named Jeannette Bankes as President and Chief Executive Officer, per Dow Jones Newswires. The leadership change lands the same evening the company reported a third-quarter loss of 10 cents per share, so the two headlines will be read together by the market. For a company with a roughly $1.25 billion market cap that posted Q2 2026 sales of $254.6 million and a $21.2 million net loss, a new CEO is a thesis-level item — strategy, spending discipline and the pump franchise roadmap all sit with this hire. The release gives no start date, no background on Bankes and no word on the outgoing CEO's status, which limits how much can be priced tonight.
At the time of this announcement, TNDM was trading at $21.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $12.26 to $29.65. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.